Back HIV Policy & Advocacy

HIV Policy & Advocacy

UNAIDS: "Fast Track" Strategy Could Help End AIDS Epidemic by 2030

A rapid acceleration of HIV prevention and treatment efforts over the next 5 years directed at people most at risk in high prevalence areas could help turn the tide in the AIDS epidemic, according to participants at a recent high-level meeting during the 69th United Nations General Assembly. If fully implemented, this approach could potentially prevent 18 million new HIV infections and 11 million deaths by 2030, as well as reducing future costs.

alt

Read more:

AIDS 2014: Australian Bone Marrow Transplant Patients Show No Detectable HIV

An additional 2 people with long-term HIV infection have no evidence of infectious virus or viral genetic material following bone marrow stem cell transplants to treat leukemia or lymphoma, researchers reported at the 20th International AIDS Conference last month in Melbourne. While these individuals remain on antiretroviral therapy (ART) and therefore cannot be considered functionally cured, they offer further evidence that HIV may be controlled off ART in some cases.

alt

Read more:

AIDS 2014: Criminalization Decreases HIV Prevention and Treatment Among Gay Men [VIDEO]

Gay and bisexual men who have been arrested or persecuted for same-sex activity are less likely to access HIV prevention services, and those who are HIV positive are less likely to receive antiretroviral treatment, according to a study presented at the 20th International AIDS Conference last month in Melbourne.

alt

Read more:

AIDS 2014: Disappointing HIV Cure News Leads to New Questions

The fourth IAS Towards an HIV Cure symposium -- an initiative of the International AIDS Society -- took place July 19-20, prior to the 20th International AIDS Conference in Melbourne.

alt

Read more:

AIDS 2014: Global ART Demand Projected to Reach 16.8 Million by 2016

The projected demand for antiretroviral therapy (ART) will increase to 16.8 million person-years by the end of 2016 in low- and middle-income countries, including 15.7 million person-years of adult and 1.1 million person-years of pediatric formulations, according to a study presented on behalf of the global ARV Forecasting Technical Working Group at the 20th International AIDS Conference(AIDS 2014) last month in Melbourne.

alt

Read more: